Evaluation of the effect of Atorvastatin in diabetic type 2 patients in the morning and evening
Not Applicable
Recruiting
- Conditions
- Evaluation of the effect of Atorvastatin administration time in the morning and evening on lipid profile in patients with type 2 diabetes.
- Registration Number
- IRCT20211211053359N1
- Lead Sponsor
- Babol University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 76
Inclusion Criteria
Any diabetic patient over the age of 40
Exclusion Criteria
People with renal failure
Patient with cancer
People who have used lipid lowering drugs before
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood levels of lipid profiles. Timepoint: At the beginning of the study and after 4 weeks. Method of measurement: Blood lipid profile (TG, HDL, LDL).
- Secondary Outcome Measures
Name Time Method Gastrointestinal complication. Timepoint: At the beginning of the administration of the drug on a daily basis. Method of measurement: Gastrointestinal complications will be recorded by the patients in the corresponding checklist on a daily basis.;Musculoskeletal complications. Timepoint: At the beginning of the administration of the drug on a daily basis. Method of measurement: Musculoskeletal complications will be recorded by the patients in the corresponding checklist on a daily basis.